{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:22:48Z","timestamp":1790079768740,"version":"4.0.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":33,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GR 2232\/9-1"],"award-info":[{"award-number":["GR 2232\/9-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHO 2052\/1-1"],"award-info":[{"award-number":["SCHO 2052\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["514598754"],"award-info":[{"award-number":["514598754"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["374031971-TRR240"],"award-info":[{"award-number":["374031971-TRR240"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004702","name":"Baxter International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.rpth.2025.102729","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T12:30:21Z","timestamp":1741782621000},"page":"102729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anti-Platelet factor 4 immunothrombosis\u2014not just heparin and vaccine triggers"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7942-3273","authenticated-orcid":false,"given":"Luisa","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata A.S.","family":"Dabbiru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Sch\u00f6nborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.102729_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.rpth.2025.102729_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9605894","article-title":"Toll-like receptor 4 signalling and its impact on platelet function, thrombosis, and haemostasis","volume":"2017","author":"Vallance","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.rpth.2025.102729_bib3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1126\/science.1256478","article-title":"Neutrophils scan for activated platelets to initiate inflammation","volume":"346","author":"Sreeramkumar","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.rpth.2025.102729_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nm1565","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.rpth.2025.102729_bib5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in\u00a0vivo","volume":"209","author":"von Br\u00fchl","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.rpth.2025.102729_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2022.2139365","article-title":"Effects of platelets activated by different agonists on fibrin formation and thrombin generation","volume":"34","author":"Muravlev","year":"2023","journal-title":"Platelets"},{"key":"10.1016\/j.rpth.2025.102729_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/a-2178-6491","article-title":"The concept of thromboinflammation","volume":"44","author":"Schrottmaier","year":"2024","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.rpth.2025.102729_bib8","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1021\/bi00193a025","article-title":"Crystal structure of recombinant human platelet factor 4","volume":"33","author":"Zhang","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.rpth.2025.102729_bib9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1182\/blood.V76.2.336.336","article-title":"Structural and functional comparison of the genes for human platelet factor 4 and PF4alt","volume":"76","author":"Eisman","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1182\/blood.2023020872","article-title":"PF4 activates the c-Mpl-Jak2 pathway in platelets","volume":"143","author":"Buka","year":"2024","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2025.102729_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ijlh.14075","article-title":"Platelet factor 4 triggers thrombo-inflammation by bridging innate and adaptive immunity","volume":"45","author":"Greinacher","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2025.102729_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cei.13417","article-title":"Novel insights into dendritic cells in the pathogenesis of systemic sclerosis","volume":"201","author":"Carvalheiro","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rpth.2025.102729_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archsurg.1958.01280200041005","article-title":"Arterial embolism occurring during systemic heparin therapy","volume":"76","author":"Weismann","year":"1958","journal-title":"AMA Arch Surg"},{"key":"10.1016\/j.rpth.2025.102729_bib14","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.7326\/0003-4819-71-6-1121","article-title":"Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy","volume":"71","author":"Natelson","year":"1969","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2025.102729_bib15","first-page":"409","article-title":"Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations","volume":"136","author":"Rhodes","year":"1973","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.rpth.2025.102729_bib16","series-title":"Anticoagulation therapy","first-page":"31","article-title":"Unfractionated heparin and low-molecular-weight heparin","author":"Malloy","year":"2018"},{"key":"10.1016\/j.rpth.2025.102729_bib17","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajh.2830450312","article-title":"Pentosan polysulfate-induced thrombocytopenia and thrombosis","volume":"45","author":"Tardy-Poncet","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.102729_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1160\/TH13-08-0634","article-title":"Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in\u00a0vitro prediction of antigenicity","volume":"112","author":"Brandt","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib19","doi-asserted-by":"crossref","first-page":"10130","DOI":"10.1039\/C5NR02132D","article-title":"Quantitative description of thermodynamic and kinetic properties of the platelet factor 4\/heparin bonds","volume":"7","author":"Nguyen","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.rpth.2025.102729_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/jth.14657","article-title":"Characterization of the interaction between platelet factor 4 and homogeneous synthetic low molecular weight heparins","volume":"18","author":"Nguyen","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.966754","article-title":"Evaluating the immunogenicity of heparin and heparin derivatives by measuring their binding to platelet factor 4 using biolayer interferometry","volume":"9","author":"Chen","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.rpth.2025.102729_bib23","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1016\/j.jtha.2023.08.020","article-title":"New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry","volume":"21","author":"Shi","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jth.12905","article-title":"Human platelet IgG Fc receptor Fc\u03b3RIIA in immunity and thrombosis","volume":"13","author":"Arman","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib25","first-page":"6921","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"12","author":"Warkentin","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.rpth.2025.102729_bib26","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-136-3-200202050-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia","volume":"136","author":"Rice","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2025.102729_bib28","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-135-7-200110020-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia and thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2025.102729_bib29","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1182\/blood-2017-06-788679","article-title":"Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma","volume":"130","author":"Mian","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1160\/TH07-06-0423","article-title":"Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: A consequence of heparin \u201cflushes.\u201d","volume":"98","author":"Refaai","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1055\/s-0031-1291375","article-title":"Heparin-induced thrombocytopenia: real-world issues","volume":"37","author":"Linkins","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2025.102729_bib32","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1182\/blood-2015-06-651620","article-title":"Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4\/heparin antibody formation after orthopedic surgery","volume":"127","author":"Bito","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1182\/blood-2015-12-687665","article-title":"Knee replacement and HIT without heparin","volume":"127","author":"Warkentin","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14945","article-title":"Anti-platelet factor 4\/polyanion antibodies mediate a new mechanism of autoimmunity","volume":"8","author":"Nguyen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.rpth.2025.102729_bib35","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 Vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib36","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib37","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib38","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib39","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.jtha.2023.06.027","article-title":"Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis","volume":"21","author":"Sch\u00f6nborn","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib40","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJMc1510993","article-title":"Heparin-induced thrombocytopenia","volume":"373","author":"Klarenbeek","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib41","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.seminhematol.2022.02.004","article-title":"Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)","volume":"59","author":"Greinacher","year":"2022","journal-title":"Semin Hematol"},{"key":"10.1016\/j.rpth.2025.102729_bib43","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.jtha.2023.06.026","article-title":"Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia","volume":"21","author":"Huynh","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib44","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.rpth.2025.102729_bib45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.seminhematol.2022.03.003","article-title":"Laboratory testing for VITT antibodies","volume":"59","author":"Warkentin","year":"2022","journal-title":"Semin Hematol"},{"key":"10.1016\/j.rpth.2025.102729_bib46","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/blood.2022016474","article-title":"Vaccine-induced immune thrombotic thrombocytopenia is mediated by a stereotyped clonotypic antibody","volume":"140","author":"Wang","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib47","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMc2402592","article-title":"Antibody fingerprints linking adenoviral anti-PF4 disorders","volume":"390","author":"Wang","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib48","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/bjh.19838","article-title":"Association of human leucocyte antigen loci with vaccine-induced immune thrombotic thrombocytopenia: potential role of the interaction between platelet factor 4-derived peptides and MHC-II","volume":"206","author":"Petito","year":"2025","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.102729_bib49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/bjh.19885","article-title":"Genetic predisposition to vaccine-induced immune thrombotic thrombocytopenia","volume":"206","author":"Arnold","year":"2025","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.102729_bib50","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s40121-023-00804-2","article-title":"Narrative review of the evolution of COVID-19 vaccination recommendations in countries in Latin America, Africa and the Middle East, and Asia","volume":"12","author":"Spinardi","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.rpth.2025.102729_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.977664","article-title":"Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1\/PD-L1 inhibitor","volume":"12","author":"Padmanabhan","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.rpth.2025.102729_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12750","article-title":"Thrombotic thrombocytopenia after Sinopharm BBIBP-CorV COVID-19 vaccination","volume":"6","author":"Hosseinzadeh","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib53","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.1002\/ajh.26272","article-title":"Cerebral venous thrombosis post BNT162b2 mRNA SARS-CoV-2 vaccination: a black swan event","volume":"96","author":"Fan","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.102729_bib54","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jth.15604","article-title":"Thrombosis and thrombocytopenia after HPV vaccination","volume":"20","author":"Johansen","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib55","doi-asserted-by":"crossref","first-page":"E363","DOI":"10.1002\/ajh.26659","article-title":"Human papilloma virus vaccine and VITT antibody induction","volume":"97","author":"Kanack","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.102729_bib56","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/M21-4502","article-title":"Case series of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination-United States, December 2020 to August 2021","volume":"175","author":"See","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2025.102729_bib57","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJMc2310644","article-title":"More on adenovirus-associated thrombocytopenia, thrombosis, and VITT-like antibodies","volume":"389","author":"Campello","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib58","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.jtha.2023.04.034","volume":"21","author":"Warkentin","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib59","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood.2023022136","article-title":"Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure","volume":"142","author":"Sch\u00f6nborn","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib60","first-page":"2010","article-title":"Cerebral venous sinus thrombosis and thrombocytopenia due to heparin-independent anti-PF4 antibodies after adenovirus infection","volume":"109","author":"Uzun","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2025.102729_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102589","article-title":"A\u00a0cluster of pediatric vaccine-induced immune thrombotic thrombocytopenia-like cases with thrombosis and thrombocytopenia following respiratory infections-case series","volume":"8","author":"Dimopoulou","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib62","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.2023021307","article-title":"Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT","volume":"143","author":"Wang","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib63","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMoa2415930","article-title":"VITT-like monoclonal gammopathy of thrombotic significance","volume":"392","author":"Wang","year":"2025","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib64","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1538-7836.2007.02617.x","article-title":"Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4\/heparin antibodies of the IgG, IgM, and IgA classes","volume":"5","author":"Greinacher","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib65","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1538-7836.2008.03025.x","article-title":"Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays","volume":"6","author":"Warkentin","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ajh.26488","article-title":"Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies","volume":"97","author":"Kanack","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.102729_bib67","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJMc2307721","article-title":"Adenovirus-associated thrombocytopenia, thrombosis, and VITT-like antibodies","volume":"389","author":"Warkentin","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib68","doi-asserted-by":"crossref","first-page":"e929","DOI":"10.1212\/CPJ.0000000000000805","article-title":"Spontaneous heparin-induced thrombocytopenia presenting as cerebral venous sinus thrombosis","volume":"11","author":"Moores","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.rpth.2025.102729_bib69","first-page":"4651","article-title":"An anti-PF4 antibody-related disorder with cerebral venous sinus thrombosis and thrombocytopenia initially presenting as intracranial hemorrhage","volume":"271","author":"Wittstock","year":"2024","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.rpth.2025.102729_bib70","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMc2413301","article-title":"Maternal anti-PF4 antibodies as cause of neonatal stroke","volume":"392","author":"H\u00e4usler","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib71","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1182\/blood-2014-04-566836","article-title":"Me or not me? The danger of spontaneity","volume":"123","author":"Greinacher","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102641","article-title":"Mini-clusters of postadenovirus VITT","volume":"9","author":"Lambert","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib73","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib74","article-title":"Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany","volume":"12","author":"Thiele","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.rpth.2025.102729_bib75","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeac036","article-title":"Early recognition and treatment of pre-VITT syndrome after adenoviral vector-based SARS-CoV-2 vaccination may prevent from thrombotic complications: review of published cases and clinical pathway","volume":"2","author":"Salih","year":"2022","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.rpth.2025.102729_bib76","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/jth.15362","article-title":"Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination","volume":"19","author":"Platton","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib77","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib78","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1182\/bloodadvances.2022007766","article-title":"The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia","volume":"6","author":"Bissola","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.102729_bib79","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMc2112760","article-title":"Decline in pathogenic antibodies over time in VITT","volume":"385","author":"Sch\u00f6nborn","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib80","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3324\/haematol.2021.279289","article-title":"Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome","volume":"106","author":"Gresele","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2025.102729_bib81","article-title":"Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance","volume":"375","author":"Pavord","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2025.102729_bib82","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.102729_bib83","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/ph17121584","article-title":"Danaparoid-consensus recommendations on its clinical use","volume":"17","author":"Bauersachs","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.rpth.2025.102729_bib84","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12959-021-00362-y","article-title":"Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis","volume":"20","author":"Myllylahti","year":"2022","journal-title":"VITT. Thrombosis J"},{"key":"10.1016\/j.rpth.2025.102729_bib85","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1182\/blood.2021013839","article-title":"The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia","volume":"139","author":"Singh","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib86","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood-2017-04-778993","article-title":"Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review","volume":"130","author":"Warkentin","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib87","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/jth.15563","article-title":"Inter- and intra-individual concentrations of direct oral anticoagulants: the KIDOAC study","volume":"20","author":"Toorop","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib88","series-title":"Updated GTH statement on vaccination with the AstraZeneca COVID-19 vaccine, as of March 22, 2021","author":"Oldenburg","year":"2021"},{"key":"10.1016\/j.rpth.2025.102729_bib89","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/j.seminhematol.2022.03.002","article-title":"Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)","volume":"59","author":"Gabarin","year":"2022","journal-title":"Semin Hematol"},{"key":"10.1016\/j.rpth.2025.102729_bib90","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1182\/blood.2021012479","article-title":"The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia","volume":"138","author":"Uzun","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib91","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJMc2109465","article-title":"Therapeutic plasma exchange in vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Patriquin","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib92","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3324\/haematol.2021.280366","article-title":"Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy","volume":"107","author":"Greinacher","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2025.102729_bib93","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1182\/blood.2022018797","article-title":"Monoclonal gammopathy of thrombotic\/thrombocytopenic significance","volume":"141","author":"Kanack","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib94","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJMc2309016","article-title":"Rescue therapy in chronic prothrombotic autoimmune anti-PF4 disorder","volume":"389","author":"Lindhoff-Last","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib95","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/bloodadvances.2019000617","article-title":"Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc\u03b3RIIA): a new option in HIT?","volume":"3","author":"Goldmann","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.102729_bib96","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1055\/a-1481-3039","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with bruton tyrosine kinase inhibitors","volume":"121","author":"Hundelshausen","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102729_bib97","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1182\/blood-2024-207999","article-title":"Platelet-activating anti-PF4 antibodies in MGUS patients with thrombosis","volume":"144","author":"Pabmanabhan","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102729_bib98","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMc2409428","article-title":"Diagnostic complexity in monoclonal gammopathy of thrombotic significance","volume":"391","author":"Kanack","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2025.102729_bib99","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMc2406453","article-title":"Myeloma therapy for monoclonal gammopathy of thrombotic significance","volume":"391","author":"Salmasi","year":"2024","journal-title":"N\u00a0Engl J Med"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T19:14:07Z","timestamp":1762629247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2475037925000536"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102729","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Platelet factor 4 immunothrombosis\u2014not just heparin and vaccine triggers","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102729"}}